000			04922nam a22002177a 4500
999			_c44919 _d44919
005			20230415092631.0
008			230402b ||||| |||| 00| 0 eng d
020			_a9781783479443
040			_cVITAP
082			_223rd Ed. _a346.048 MAT
245			_aResearch Handbook on Intellectual Property and the Life Sciences / _cedited by Duncan Matthews and Herbert Zech
260			_aCheltenham, UK _bEdward Elgar Publishing Limited _c2017
300			_axix, 503p. : ill. ; 25cm
440			_911456 _aResearch Handbooks in Intellectual Property
500			_aIt includes Index Pages. Description: Intellectual property (IP) is a key component of the life sciences, which is becoming one of the most dynamic and innovative fields of technology today. At the same time, the relationship between IP and the life sciences is raising new public policy dilemmas. The Research Handbook on Intellectual Property and the Life Sciences comprises contributions by leading experts from academia and industry that confront current debates and controversies at the intersection of IP and the life sciences through in-depth analyses of key topics including pharmaceuticals, diagnostics and genes, plant innovations, stem cells, the role of competition law and access to medicines. The first section of this book highlights the importance of IP for medicines and pharmaceuticals, discussing topics including gene patents, and the second section deals with agricultural sector issues such as plant innovations. The third section of the book covers areas of research and development in the life sciences, such as stem cell research, and raises questions about incorporating ethical considerations into patent law. While the primary focus of the book is on Europe and the United States, the fourth section includes country-specific case studies on Australia, Brazil, China, India, Japan, Kenya, South Africa and Thailand to provide a truly international perspective. This Research Handbook is written in an accessible style that will appeal to intellectual property law scholars, practitioners and experts in the life sciences who are interested in the legal implications of IP for the life sciences. Table of Contents: Preface Part I - Medicine and Pharmaceutics 1. Patenting Biosimilars Claudia Mund 2. Patenting Diagnostics Dieter Wächter 3. Patenting Human Genes in Europe- And how it compares to the US and Australia Timo Minssen 4. Patenting Human Genes in the United States Samantak Gosh 5. An Exorbitant Monopoly: The High Court of Australia, Myriad Genetics, and Gene Patents Matthew Rimmer 6. Exclusivity for Biologics Duncan Matthews Part II - Agricultural Sector (Crop Sciences) 7. Protection of Plant Innovations Gert Würtenberger 8. Patenting Non Transgenic Plants in the EU Michael A. Kock 9. Non-Obvious Plants Mark D. Janis 10. Transgenic Plants James Allred 11. Convention on Biological Diversity and Regulatory Law as Plant Protection Claudio Chiarolla 12. Patents on Native Traits: What Scope of Protection? Axel Metzger Part III - Research and Development 13. The European Union’s IP Policy and Funding of Stem Cell Research Aurora Plomer 14. Stem Cell Patents in the United States John M. Golden 15. Early Stage Patenting, the US Bayh-Dole Act, and the Anti-Commons Hypothesis Charles R. McManis and Brian Yagi 16. IP in Research and Development Agreements Melanie Graf and Herbert Zech 17. Patent pools and clearinghouses in the life sciences: back to the future Geertrui Van Overwalle Part IV - Country Case Studies in IP and the Life Sciences 18. Understanding the Brazilian Patent Reform Pedro Paranaguá 19. IP protection in the life sciences in China Lin Xiuqin and Zhang Xinfeng 20. Diverse Harmonization: Indian Example Srividhya Ragavan 21. Life Science Research and Patents in Japan: A Comparative Study of Life Science Invention Patentability between the Japanese and US Patent Acts Toshiko Takenaka 22. Intellectual Property and the Life Sciences in Kenya: Enforcement and Access to Medicines John Harrington 23. IP and Life Sciences: A Case Study of South Africa Tenu Avafia 24. Thailand’s Compulsory Licenses and the Increase of Investment Arbitration David B. Degen Part V - Boundaries of IP and the Life Sciences 25. Parallel Imports within the European Union Gert Würtenberger 26. Pay for Delay Agreements Claudia Seitz 27. Abusive Filing of IP Rights Andreas Heinemann Index
650		0	_911457 _aIntellectual property; Biotechnology industries--Law and legislation; Life sciences
700			_911766 _aMatthews, Duncan, ed.
700			_911767 _aZech, Herbert., ed.
856			_uhttps://www.e-elgar.com/shop/gbp/research-handbook-on-intellectual-property-and-the-life-sciences-9781783479443.html
942			_2ddc _cREF _e23rd _h346.048 _mMAT